Aksys (AKSY) Stock Price, News & Analysis

Company Overview

Aksys was a medical device company focused on developing technologies for kidney dialysis and renal replacement therapy. Its work centered on making hemodialysis more compact, automated and suitable for use outside traditional dialysis centers.

The company’s principal product was the PHD System, an automated hemodialysis system designed for home use. The system incorporated technology intended to regenerate and reuse dialysate, potentially reducing the amount of water and dialysis fluid required for treatment compared with conventional systems.

Aksys operated primarily in the United States and was historically associated with the development of home and portable dialysis equipment. Publicly available information about the company’s later operations, current leadership and commercial activities is limited.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 10/14/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: OTCMKTS:AKSY
• CIK: N/A
• Web: www.aksys.com
• Phone: (847) 247-6051
• Fax: 847-229-2080
• Employees: 87
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A